Frontiers of Chemical Science and Engineering
>> 2014,
Volume 8,
Issue 3
doi:
10.1007/s11705-014-1439-5
RESEARCH ARTICLE
Development of a multi-component drug from turmeric using central composite design
Key Laboratory of Systems Bioengineering, Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
Accepted: 2014-08-15
Available online: 2014-10-11
Next
Previous
Abstract
A methodology to develop multi-component drugs based on traditional Chinese medicines has been developed using central composite design. Several active components from the traditional Chinese medicine turmeric were chosen for use in a multi-component antitumor drug. Response surface methodology based on a central composite design was applied to determine the quantitative composition-activity relationships in order to optimize the amount of each component in the drug. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to measure the pharmacological activity as the response value. The experimental antitumor activity of the optimum combination was 92.85% in the MTT assay and superior to the activities of each single component. These results demonstrate that response surface methodology based on a central composite design is suitable for the design of multi-component drugs.
京公网安备 11010502051620号
